BeStock  

Bausch + Lomb Corp. BLCO

US equityMarket cap rank #1739Medical Instruments & Supplies
$19.38 −$1.31 (-6.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.40 +0.10%
Open$20.24
Prev close$20.69
Day range$19.30 – $20.50
Volume872.1K
Market cap$6.93B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.9%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+15.8%
Worst reaction-15.7%

Stock move on the day after each report

+13.8%2023/Q4-5.5%2024/Q1+2.1%2024/Q2-1.5%2024/Q3-0.3%2024/Q4-15.7%2025/Q1-6.4%2025/Q2+1.8%2025/Q3-0.3%2025/Q4-2.4%2026/Q1-2.5%2026/Q2+15.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q328 Oct 2026Pre Market±10.1%+15.78%Bigger than priced
2026/Q229 Jul 2026Pre Market±10.5%-2.47%Within range
2026/Q129 Apr 2026Pre Market±18.5%-2.42%Within range
2025/Q418 Feb 2026Pre Market±23.9%-0.34%Within range
2025/Q329 Oct 2025Pre Market±11.0%+1.78%Within range
2025/Q230 Jul 2025Pre Market±11.4%-6.42%Within range
2025/Q130 Apr 2025Pre Market±12.6%-15.74%Bigger than priced
2024/Q419 Feb 2025None±12.9%-0.31%Within range
2024/Q330 Oct 2024Pre Market±15.0%-1.54%Within range
2024/Q231 Jul 2024Pre Market±15.8%+2.07%Within range
2024/Q11 May 2024Pre Market±16.3%-5.50%Within range
2023/Q421 Feb 2024Pre Market±13.7%+13.78%Bigger than priced
2023/Q31 Nov 2023Pre Market±9.4%+2.35%Within range
2023/Q22 Aug 2023None±11.6%-2.27%Within range
2023/Q13 May 2023None±14.3%+1.72%Within range
2022/Q422 Feb 2023None±10.8%-3.94%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Vision Care$774.00M 56.3%
  • Pharmaceuticals$367.00M 26.7%
  • Surgical$234.00M 17.0%

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.38B+7.3% YoY
Operating profit$185.00M+131.3% YoY
Net profit$35.00M+240.0% YoY
Diluted EPS$0.09+212.5% YoY
Free cash flow$178.00M+182.5% YoY
Operating cash flow$233.00M

Revenue, last 8 quarters

$1.3BDec '24$1.1BMar '25$1.3BJun '25$1.3BSep '25$1.4BDec '25$1.2BMar '26$1.4BJun '26$1.4BSep '26

Net profit, last 8 quarters

$-2.0MDec '24$-211.0MMar '25$-58.0MJun '25$-25.0MSep '25$-58.0MDec '25$-70.0MMar '26$-10.0MJun '26$35.0MSep '26

Profitability & balance sheet

Gross margin62.6%
Operating margin9.4%
Net margin-2.0%
Return on equity-1.7%
Return on assets-0.8%
Return on invested capital1.0%
Current ratio1.56
Liabilities / assets53.4%
Cash & investments$513.00M
Total debt$5.10B
Net cash (debt)-$4.58B
Free cash flow / sales4.7%

Discussion

No comments yet — be the first to weigh in on BLCO.

Sign in to join the discussion.

Scroll to Top